Potential Role of an Endothelium-Specific Growth Factor, Hepatocyte Growth Factor, on Endothelial Damage in Diabetes

Ryuichi Morishita(The University of Osaka), Toshio Ogihara(Osaka University), Motokuni Aoki(Osaka City University), Iwao Kida(The University of Osaka), Toshikazu Nakamura(The University of Osaka), Yoshio Nakamura(Tokyo Institute of Technology), Shigefumi Nakamura(The University of Osaka), Atsushi Moriguchi(The University of Osaka), Kunio Matsumoto(Kanazawa University), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Yoshikage Yo(The University of Osaka)
Diabetes
January 1, 1997
10.2337/diab.46.1.138
Cited by 124

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588